MedPath

Azulfidine

Azulfidine sulfasalazine tablets, USP

Approved
Approval ID

ddbe69f3-bd55-45f3-a64f-f60226c744c4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 26, 2022

Manufacturers
FDA

Pfizer Laboratories Div Pfizer Inc

DUNS: 134489525

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sulfasalazine

PRODUCT DETAILS

NDC Product Code0013-0101
Application NumberNDA007073
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateOctober 26, 2022
Generic NameSulfasalazine

INGREDIENTS (5)

SULFASALAZINEActive
Quantity: 500 mg in 1 1
Code: 3XC8GUZ6CB
Classification: ACTIB
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Azulfidine - FDA Approval | MedPath